Paper Details

  1. Home
  2. Paper Details

Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.

Author: HuntB, ModyR, PerezM C, PeuraD A, PilmerB

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Dexlansoprazole appears to be effective in improving both heartburn and regurgitation in patients with non-erosive GERD (NERD) and erosive oesophagitis (EE).
Paper Details　
Original Abstract of the Article :
BACKGROUND: Gastro-oesophageal reflux disease (GERD) is characterised by symptomatic heartburn and regurgitation. Treatment with proton pump inhibitors (PPI) effectively decreases heartburn symptoms, but their effects on symptomatic regurgitation are less clear. AIM: To determine the impact of PPI ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/apt.12504

データ提供：米国国立医学図書館（NLM）

Dexlansoprazole: A Solution for Heartburn and Regurgitation in the Desert of GERD

Gastroesophageal reflux disease (GERD) is a prevalent condition, often characterized by the unpleasant symptoms of heartburn and regurgitation, like a persistent burning sensation in the desert of your digestive system. This study, akin to a well-equipped caravan, explores the effectiveness of dexlansoprazole, a proton pump inhibitor (PPI), in alleviating these symptoms.

Dexlansoprazole: A Beacon of Relief in the GERD Desert

The research revealed that dexlansoprazole effectively improved both heartburn and regurgitation symptoms in patients with GERD, regardless of whether they had non-erosive GERD (NERD) or erosive esophagitis (EE). Patients who received dexlansoprazole experienced significant improvements in symptom severity compared to those who received a placebo.

Navigating the Desert of GERD Symptoms

This study offers valuable insights for those navigating the desert of GERD. Dexlansoprazole appears to be a promising option for alleviating both heartburn and regurgitation, providing much-needed relief for those suffering from these debilitating symptoms. As with any oasis in the desert, it is important to consult with a healthcare professional to determine the most appropriate treatment approach.

Dr.Camel's Conclusion

This study offers a valuable oasis of hope for those seeking relief from the discomfort of GERD. Dexlansoprazole demonstrates its effectiveness in alleviating both heartburn and regurgitation, potentially improving the quality of life for countless individuals battling this condition. As with any journey through the desert of GERD, it is important to consult with a healthcare professional for personalized guidance and treatment.

Date :
  1. Date Completed 2014-09-26
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

24118079

DOI: Digital Object Identifier

10.1111/apt.12504

Related Literature

Article Analysis
・Effective treatment of gerd
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.